Abraham Jacob, MD
Otology & Neurotology · Tucson, AZNPI 1376592576
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Cochlear Americas at 50.2% of the total. 2025 is the largest year on record at $10,594, 8.4 times the $1,257 reported in 2019.
Across 68 payments — averaging $302.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cochlear Americas$10K
- Med-el Corporation$10K
- Advanced Bionics, LLC$198
- Oticon Medical, LLC$121
- Acclarent, Inc$80
- AstraZeneca$21
- plus $37 from 3 others
Across 74 payments — averaging $9099.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cochlear Americas$673K
What the payments were for
- Consulting fees$8,05039%
- Speaking & faculty fees$3,60017%
- Travel & lodging$4,79923%
- Food & beverage$4,14320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cochlear Americas | 43 | $10,333 |
| Med-el Corporation | 16 | $9,802 |
| Advanced Bionics, LLC | 3 | $198 |
| Oticon Medical, LLC | 1 | $121 |
| Acclarent, Inc | 1 | $80 |
| AstraZeneca | 1 | $21 |
| UCB, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Aucta Pharmaceuticals, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few otology & neurotology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 69 | $722 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 70 | $489 |
| Ondansetron Hcl | 72 | $210 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Tucson
- Deborah XiePhoenix$7K
- Thomas KangOro Valley$6K
- Adam CassisChandler$6K
- Mark SymsPhoenix$4K
- Peter WeisskopfScottsdale$3K
- Samuel BarberPhoenix$3K
- Michael FucciChandler$723
- John MaciasPhoenix$480
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.